Docusign Inc. (NASDAQ:DOCU – Get Free Report) insider Robert Chatwani sold 13,818 shares of Docusign stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total transaction of $944,183.94. Following the completion of the sale, the insider directly owned 70,197 shares of the company’s stock, valued at approximately $4,796,561.01. This trade represents a 16.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Robert Chatwani also recently made the following trade(s):
- On Monday, December 15th, Robert Chatwani sold 1,683 shares of Docusign stock. The stock was sold at an average price of $70.87, for a total transaction of $119,274.21.
- On Thursday, December 11th, Robert Chatwani sold 983 shares of Docusign stock. The shares were sold at an average price of $68.62, for a total value of $67,453.46.
Docusign Stock Performance
DOCU stock opened at $69.40 on Friday. The stock’s 50 day simple moving average is $68.93 and its 200 day simple moving average is $74.18. The company has a market cap of $13.90 billion, a P/E ratio of 48.53, a price-to-earnings-growth ratio of 3.40 and a beta of 0.98. Docusign Inc. has a fifty-two week low of $63.41 and a fifty-two week high of $99.30.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on DOCU. BTIG Research assumed coverage on Docusign in a research report on Tuesday. They set a “buy” rating and a $88.00 target price on the stock. Wells Fargo & Company lowered their price objective on shares of Docusign from $85.00 to $75.00 and set an “equal weight” rating on the stock in a report on Friday, December 5th. Piper Sandler dropped their price objective on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. UBS Group decreased their target price on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Finally, JMP Securities restated a “market outperform” rating and issued a $124.00 target price on shares of Docusign in a report on Friday, October 3rd. Six investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $86.80.
Get Our Latest Analysis on DOCU
About Docusign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than Docusign
- How to Calculate Options Profits
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Why is the Ex-Dividend Date Significant to Investors?
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- Best Energy Stocks – Energy Stocks to Buy Now
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
